The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy by Angioletta Lasagna, Dalila Mele, Federica Bergami, Domiziana Alaimo, Chiara Dauccia, Nicolò Alessio, Giuditta Comolli, Francesca Pasi, Alba Muzzi, Viola Novelli, Fausto Baldanti, Paolo Pedrazzoli, Irene Cassaniti

Get full text